What top creators are saying about Hims & Hers Health, Inc.(HIMS)— Page 8
351 AI-extracted insights from 40 sources — podcasts, YouTube channels, and X/Twitter accounts.
Insights about Hims & Hers Health, Inc. (HIMS) — Page 8 of 8
Showing insights 351–351 of 351.
Monday, June 23, 2025
Very Bearish
Target: $28
Novo Nordisk terminated its partnership with the company, and Bank of America reiterated a sell rating with a $28 price target, citing concerns of decelerating revenue growth.
Monday, June 23, 2025
Very Bearish
Target: $28
Novo Nordisk terminated its partnership with the company, and Bank of America reiterated a sell rating with a $28 price target, citing concerns of decelerating revenue growth.